Bing Kung
Vice President
bing.kung@torreyapartners.com
(212) 331-7849
Bing has worked on over 50 life science financing and M&A transactions in recent years as an investment banker. Prior to Torreya he worked at MTS Health Partners and Aquilo Partners. Bing is a former research scientist in the Division of Oncology and the Division of Neurology at The Children's Hospital of Philadelphia, where he authored a number of peer-reviewed publications on the molecular basis of the pediatric solid tumor neuroblastoma. Bing received his Master of Biotechnology and B.A. in Biology from the University of Pennsylvania.
Selected Transaction Experience:
• Columbia Labs, Sale of Progesterone Related Assets to Watson, $107.5 million (pending)
• Aradigm, Registered Direct Financing, $4.5 million (2009)
• Ikonisys, Partnership of oncoFISH Cervical with Enzo Biochem (2009)
• Nabi Biopharmaceuticals, Sale of PentaStaph to GlaxoSmithKline, $47.5 million (2009)
• ARIUS Research, Sale to Roche, $189 million (2008)
• Complete Genomics, Series C Preferred (2008)
• GTC Biotherapeutics, Convertible Debt, $15 million (2008)
• Open Biosystems, Sale to Thermo Fisher (2008)
• Oscient Pharmaceuticals, Convertible Debt Exchange Offer, $213 million (2008)
• Threshold Pharmaceuticals, PIPE Offering of Common Stock, $18 million (2008)
• Epocal, Series C Preferred, $31 million (2007)
• Gene Logic, Sale of Genomics Division to Ocimum (2007)
• GlobeImmune, Series C Preferred, $41 million (2007)
• Laboratory Partners, Series B and D Preferred & Debt, $69 million (2007)
• Protedyne, Sale to LabCorp (2007)
• QuatRx, Series E Preferred, $44 million (2007)
• Aerovance, Series C Preferred, $60 million (2006)
• Applied Imaging, Sale to Genetix, $26 million (2006)
• Solstice Neurosciences, Series B Preferred & Debt, $85 million (2006)
Bing is a registered representative with Financial West Group, Torreya’s financing partner.
Copyright © 2010 Torreya Partners LLC. All rights reserved.
Securities offered through Financial West Group, member FINRA/SIPC. Torreya Partners LLC and Financial West Group are unaffiliated entities.